AI assistant
BIOGEN INC. — Director's Dealing 2013
Sep 18, 2013
30291_dirs_2013-09-18_f4fad68e-8f82-44d4-9d2e-52a66ad1a893.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2013-09-16
Reporting Person: Clancy Paul J (Executive VP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-16 | Common Stock | M | 10990 | $44.24 | Acquired | 18077 | Direct |
| 2013-09-16 | Common Stock | S | 2500 | $237.046 | Disposed | 15577 | Direct |
| 2013-09-16 | Common Stock | S | 5165 | $238.118 | Disposed | 10412 | Direct |
| 2013-09-16 | Common Stock | S | 1525 | $239.004 | Disposed | 8887 | Direct |
| 2013-09-16 | Common Stock | S | 1800 | $239.842 | Disposed | 7087 | Direct |
| 2013-09-16 | Common Stock | M | 6000 | $41.03 | Acquired | 13087 | Direct |
| 2013-09-16 | Common Stock | S | 1600 | $237.049 | Disposed | 11487 | Direct |
| 2013-09-16 | Common Stock | S | 2825 | $238.292 | Disposed | 8662 | Direct |
| 2013-09-16 | Common Stock | S | 1475 | $239.537 | Disposed | 7187 | Direct |
| 2013-09-16 | Common Stock | S | 100 | $240.20 | Disposed | 7087 | Direct |
| 2013-09-16 | Common Stock | M | 18100 | $49.31 | Acquired | 25187 | Direct |
| 2013-09-16 | Common Stock | S | 4400 | $237.052 | Disposed | 20787 | Direct |
| 2013-09-16 | Common Stock | S | 7221 | $238.124 | Disposed | 13566 | Direct |
| 2013-09-16 | Common Stock | S | 3269 | $238.802 | Disposed | 10297 | Direct |
| 2013-09-16 | Common Stock | S | 3210 | $239.793 | Disposed | 7087 | Direct |
| 2013-09-16 | Common Stock | M | 20000 | $63.55 | Acquired | 27087 | Direct |
| 2013-09-16 | Common Stock | S | 4227 | $236.988 | Disposed | 22860 | Direct |
| 2013-09-16 | Common Stock | S | 7503 | $237.998 | Disposed | 15357 | Direct |
| 2013-09-16 | Common Stock | S | 4300 | $238.648 | Disposed | 11057 | Direct |
| 2013-09-16 | Common Stock | S | 3970 | $239.757 | Disposed | 7087 | Direct |
| 2013-09-16 | Common Stock | M | 43940 | $60.56 | Acquired | 51027 | Direct |
| 2013-09-16 | Common Stock | S | 9000 | $236.943 | Disposed | 42027 | Direct |
| 2013-09-16 | Common Stock | S | 14708 | $237.933 | Disposed | 27319 | Direct |
| 2013-09-16 | Common Stock | S | 11134 | $238.564 | Disposed | 16185 | Direct |
| 2013-09-16 | Common Stock | S | 9098 | $239.754 | Disposed | 7087 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-16 | Stock Option (Right to Buy) | $44.24 | M | 10990 | Disposed | 2016-02-06 | Common Stock (10990) | Direct |
| 2013-09-16 | Stock Option (Right to Buy) | $41.03 | M | 6000 | Disposed | 2016-08-01 | Common Stock (6000) | Direct |
| 2013-09-16 | Stock Option (Right to Buy) | $49.31 | M | 18100 | Disposed | 2017-02-12 | Common Stock (18100) | Direct |
| 2013-09-16 | Stock Option (Right to Buy) | $63.55 | M | 20000 | Disposed | 2017-09-03 | Common Stock (20000) | Direct |
| 2013-09-16 | Stock Option (Right to Buy) | $60.56 | M | 43940 | Disposed | 2018-02-11 | Common Stock (43940) | Direct |
Footnotes
F1: Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: This represents the weighted average price for shares sold at a range between $236.52 (low) and $237.43 (high).
F3: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F4: This represents the weighted average price for shares sold at a range between $237.53 (low) and $238.52 (high).
F5: This represents the weighted average price for shares sold at a range between $238.55 (low) and $239.51(high).
F6: This represents the weighted average price for shares sold at a range between $239.62 (low) and $240.22(high).
F7: This represents the weighted average price for shares sold at a range between $236.57 (low) and $237.48(high).
F8: This represents the weighted average price for shares sold at a range between $237.82 (low) and $238.74 (high).
F9: This represents the weighted average price for shares sold at a range between $238.92 (low) and $239.90 (high).
F10: This represents the weighted average price for shares sold at a range between $236.46 (low) and $237.43 (high).
F11: This represents the weighted average price for shares sold at a range between $237.48 (low) and $238.46 (high).
F12: This represents the weighted average price for shares sold at a range between $238.48 (low) and $239.47 (high).
F13: This represents the weighted average price for shares sold at a range between $239.53 (low) and $240.35 (high).
F14: This represents the weighted average price for shares sold at a range between $236.33 (low) and $237.32 (high).
F15: This represents the weighted average price for shares sold at a range between $237.36 (low) and $238.36 (high).
F16: This represents the weighted average price for shares sold at a range between $238.38 (low) and $239.35 (high).
F17: This represents the weighted average price for shares sold at a range between $239.45 (low) and $240.20 (high).
F18: This represents the weighted average price for shares sold at a range between $236.31 (low) and $237.30 (high).
F19: This represents the weighted average price for shares sold at a range between $237.31 (low) and $238.31 (high).
F20: This represents the weighted average price for shares sold at a range between $238.31 (low) and $239.29 (high).
F21: This represents the weighted average price for shares sold at a range between $239.36 (low) and $240.32 (high).
F22: The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/06/06.
F23: The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 8/01/06.
F24: The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/07.
F25: The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 09/04/2007.
F26: The stock options become exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/12/2008.